Annual report pursuant to Section 13 and 15(d)

EARNINGS PER SHARE - Narrative (Details)

v3.20.1
EARNINGS PER SHARE - Narrative (Details)
12 Months Ended
May 22, 2019
shares
Dec. 28, 2019
shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Spinoff transaction, conversion ratio 0.1428571429  
Number of shares outstanding (in shares) 56,647,561  
Stock Option    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Stock options excluded from computation of earnings per share (in shares)   100,000
Performance-based    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Stock options excluded from computation of earnings per share (in shares)   300,000